Biotest Aktiengesellschaft (BIO3) — Capital Reinvestment Ratio
Biotest Aktiengesellschaft (BIO3) has a Capital Reinvestment Ratio of 0.50x as of December 2023, meaning it reinvests 0% of its operating cash flow (€67.40 Million) in capital expenditures (€33.40 Million). Check Biotest Aktiengesellschaft (BIO3) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Biotest Aktiengesellschaft Capital Reinvestment Ratio (2002–2024)
This chart tracks Biotest Aktiengesellschaft's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see BIO3 cash flow conversion.
Annual Capital Reinvestment Ratio for Biotest Aktiengesellschaft (2002–2024)
Year-by-year Capital Reinvestment Ratio for Biotest Aktiengesellschaft from 2002 to 2024. See Biotest Aktiengesellschaft (BIO3) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.47x | €60.90 Million | €28.70 Million | ▼ -12.2% |
| 2021 | 0.54x | €33.90 Million | €18.20 Million | ▼ -82.7% |
| 2017 | 3.10x | €34.30 Million | €106.50 Million | ▲ +42.2% |
| 2016 | 2.18x | €65.90 Million | €143.90 Million | ▼ -17.4% |
| 2015 | 2.64x | €38.10 Million | €100.70 Million | ▲ +166.0% |
| 2012 | 0.99x | €34.73 Million | €34.51 Million | ▲ +168.8% |
| 2011 | 0.37x | €72.28 Million | €26.72 Million | ▼ -2.1% |
| 2010 | 0.38x | €77.83 Million | €29.37 Million | ▼ -70.2% |
| 2009 | 1.27x | €31.68 Million | €40.17 Million | ▲ +19.7% |
| 2008 | 1.06x | €34.49 Million | €36.54 Million | ▲ +43.9% |
| 2004 | 0.74x | €25.29 Million | €18.62 Million | ▼ -40.7% |
| 2003 | 1.24x | €16.52 Million | €20.51 Million | ▼ -90.1% |
| 2002 | 12.52x | €2.46 Million | €30.80 Million | — |